We are live on ! Find out more
Pacer Advisors

Pacer Advisors Portfolio holdings

AUM $35.6B
1-Year Est. Return 18.19%
This Fund
S&P 500
This Quarter Est. Return
+7.25%
1 Year Est. Return
+18.19%
3 Year Est. Return
+46.13%
5 Year Est. Return
+70.99%
10 Year Est. Return
+394.12%
AUM
$6.99B
AUM Growth
+$1.23B
Cap. Flow
-$140M
Cap. Flow %
-2%
Top 10 Hldgs %
22.95%
Holding
1,634
New
85
Increased
643
Reduced
463
Closed
238

Top Buys

Rank Stock Value
1
DBRG icon
DigitalBridge
DBRG
+$21.6M
2
GDS icon
GDS Holdings
GDS
+$16.6M
3
DELL icon
Dell
DELL
+$12.3M
4
PARA
Paramount Global Class B
PARA
+$12M
5
LUMN icon
Lumen
LUMN
+$11M

Top Sells

Rank Stock Value
1
CCI icon
Crown Castle
CCI
+$11.5M
2
AAPL icon
Apple
AAPL
+$9.2M
3
LOW icon
Lowe's Companies
LOW
+$8.79M
4
PTMC icon
Pacer Trendpilot US Mid Cap ETF
PTMC
+$8.38M
5
PTLC icon
Pacer Trendpilot US Large Cap ETF
PTLC
+$8.36M

Sector Composition

Rank Sector Weight
1 Real Estate 16.24%
2 Technology 13.67%
3 Consumer Discretionary 10.4%
4 Healthcare 8.54%
5 Communication Services 6.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
APLS
1251
DELISTED
Apellis Pharmaceuticals
APLS
– –
-1,669
Closed -$72K
ARCT icon
1252
Arcturus Therapeutics
ARCT
$164M
– –
-1,578
Closed -$65K
ARDX icon
1253
Ardelyx
ARDX
$1.25B
– –
-3,896
Closed -$26K
ARQT icon
1254
Arcutis Biotherapeutics
ARQT
$3.48B
– –
-887
Closed -$26K
ATRA icon
1255
Atara Biotherapeutics
ATRA
$69.5M
– –
-184
Closed -$66K
AVNS icon
1256
Avanos Medical
AVNS
$1.17B
– –
-5,120
Closed -$224K
AVXL icon
1257
Anavex Life Sciences
AVXL
$232M
– –
-2,786
Closed -$42K
BBIO icon
1258
BridgeBio Pharma
BBIO
$16.5B
– –
-1,103
Closed -$68K
BCRX icon
1259
BioCryst Pharmaceuticals
BCRX
$2.43B
– –
-6,177
Closed -$63K
BDTX icon
1260
Black Diamond Therapeutics
BDTX
$99.1M
– –
-2,369
Closed -$57K
BEAM icon
1261
Beam Therapeutics
BEAM
$2.58B
– –
-791
Closed -$63K
BLUE
1262
DELISTED
bluebird bio
BLUE
– –
-186
Closed -$73K
BMRN icon
1263
BioMarin Pharmaceuticals
BMRN
$11.6B
– –
-1,019
Closed -$77K
BN icon
1264
Brookfield
BN
$103B
– –
-19,903
Closed -$474K
BPMC
1265
DELISTED
Blueprint Medicines
BPMC
– –
-724
Closed -$70K
BRFS
1266
DELISTED
BRF SA
BRFS
– –
-6,348
Closed -$29K
BTAI icon
1267
BioXcel Therapeutics
BTAI
$26.8M
– –
-104
Closed -$72K
BUL icon
1268
Pacer US Cash Cows Growth ETF
BUL
$129M
– –
-8,692
Closed -$310K
CALF icon
1269
Pacer US Small Cap Cash Cows 100 ETF
CALF
$3.64B
– –
-9,092
Closed -$373K
CCCC icon
1270
C4 Therapeutics
CCCC
$397M
– –
-1,096
Closed -$41K
CDNA icon
1271
CareDx
CDNA
$1.88B
– –
-1,154
Closed -$79K
CHRS icon
1272
Coherus Oncology
CHRS
$225M
– –
-105,431
Closed -$1.54M
CIVI
1273
DELISTED
Civitas Resources
CIVI
– –
-29,968
Closed -$1.07M
CLDX icon
1274
Celldex Therapeutics
CLDX
$2.8B
– –
-2,828
Closed -$58K
COWZ icon
1275
Pacer US Cash Cows 100 ETF
COWZ
$18.5B
– –
-8,489
Closed -$345K
49 50
51
52 53

Similar funds

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
MML Investors Services
MML Investors Services Springfield, Massachusetts $36.1B AUM 19.68% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
SAM
Storebrand Asset Management Lysaker, Norway $34.8B AUM 25.49% 1-Year Est. Return
Daiwa Securities Group
Daiwa Securities Group Tokyo, Japan $34.8B AUM 20.7% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return

Pacer Advisors's Q2 2021 Portfolio in Review

As of Q2 2021, Pacer Advisors held 1,634 positions worth $6.99B, up 21% from $5.75B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Pacer Advisors's Q2 2021 filing shows 85 new, 643 increased, 463 reduced and 238 closed positions. Its largest new stake was DigitalBridge: 754,679 shares worth $23.8M. The largest sale was Crown Castle, an estimated $11.5M.

By sector, the portfolio is most concentrated in Real Estate at 16% of assets, down from 17% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Pacer Advisors's largest Q2 2021 buy was DigitalBridge: 754,679 shares worth $23.8M.
  • Pacer Advisors added most to GDS Holdings in Q2 2021, an estimated $16.6M increase.
  • Pacer Advisors's biggest Q2 2021 reduction was Crown Castle, cutting an estimated $11.5M.
  • Pacer Advisors fully exited Pacer Trendpilot US Mid Cap ETF in Q2 2021, selling an estimated $8.38M.
  • Pacer Advisors's ten largest holdings make up 23% of its $6.99B portfolio in Q2 2021.
  • Pacer Advisors opened 85 new positions and closed 238 in Q2 2021.
  • Pacer Advisors's portfolio value rose 21% quarter-over-quarter to $6.99B.

Based on Pacer Advisors's 13F filing for Q2 2021, filed 21 Jul 2021.